Aveva Drug Delivery Systems
- Company typePrivate
- Founded2023
- HeadquartersMiramar Beach, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Aveva Drug Delivery Systems firmographics
Firmographics- Name
- Aveva Drug Delivery Systems
- Legal name
- Aveva Drug Delivery Services Inc.
- Website
- https://avevadds.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Aveva Drug Delivery Systems industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where Aveva Drug Delivery Systems is headquartered
LocationHeadquarters
- HQ city
- Miramar Beach
- HQ country
- United States
- HQ region
- North America
Markets served
Aveva Drug Delivery Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure
Aveva Drug Delivery Systems product offering
Product offeringCore offering
Aveva Drug Delivery Systems is a contract manufacturing organization (CMO) that produces transdermal delivery systems (skin patches) and oral dissolvable thin films for pharmaceutical partners. The company specializes in complex drug delivery dosage forms used for personalized medicine, providing formulation and production capabilities to pharmaceutical companies that require advanced, US-based manufacturing.
Product overview
Aveva Drug Delivery Services is a contract manufacturing organization (CMO) specializing in complex drug delivery dosage forms. The company offers two core product lines: Transdermal Delivery Systems and Oral Dissolvable Films. These manufacturing capabilities were enhanced when DifGen Pharmaceuticals acquired Aveva in April 2023 to establish a US-based manufacturing hub and boost supply chain resilience for pharmaceutical partners.
Differentiator
Problem solved
Functional benefit
Products and services
- Transdermal Delivery Systems Transdermal patch delivery systems that administer medications through the skin for controlled drug release. Manufactured as a contract service for pharmaceutical companies developing transdermal therapeutic products.
- Oral Dissolvable Films Oral thin films that dissolve in the mouth for quick-acting therapeutic drug delivery. Manufactured as a contract service for pharmaceutical partners requiring rapid-onset buccal or sublingual formulations.
Companies that use Aveva Drug Delivery Systems
Customer profileSegments1 record
Ideal customer profiles1 record
Aveva Drug Delivery Systems technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Aveva Drug Delivery Systems partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Callan JMB Inc.minorCallan JMB Inc. is involved in manufacturing oversight for the JKB-122 Long COVID drug trial collaboration. The company stated it believes the claims lack merit and that the litigation does not affect its operations or ongoing projects.
- Biostax Corp (Attune Biotech)coreBiostax Corp (Attune Biotech) is part of a U.S.-based collaboration with Aveva Drug Delivery Systems to support scale-up of the Lodonal immune platform for Phase 2b/3 clinical development. Callan JMB acts as independent oversight partner validating manufacturing, quality, and supply chain operations.
- SGP HoldingscoreSGP Holdings is part of a U.S.-based collaboration with Aveva Drug Delivery Systems to support scale-up of the Lodonal immune platform for Phase 2b/3 clinical development. Callan JMB acts as independent oversight partner validating manufacturing, quality, and supply chain operations.
- Callan JMB Inc.minorCallan JMB Inc. acts as independent oversight partner validating manufacturing, quality, and supply chain operations for the Lodonal immune platform collaboration, ensuring compliance and readiness for large-scale deployment aligned with U.S. federal agencies.
- DifGen Pharmaceuticals LLCcoreIn April 2023, DifGen Pharmaceuticals LLC acquired Aveva Drug Delivery Services Inc. to enhance its research and manufacturing capabilities for complex drug delivery dosage forms, establish a US-based manufacturing hub, and boost supply chain resilience.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Aveva Drug Delivery Systems competitors and assessment
Company assessmentDirect peers
- IntelGenx Technologies Corp: IntelGenx is a drug delivery company specializing in oral thin film formulations (VersaFilm technology), directly comparable to Aveva's oral dissolvable film capabilities. Both target pharmaceutical partners seeking advanced oral drug delivery manufacturing.
- Noven Pharmaceuticals (Hisamitsu): Noven, a subsidiary of Hisamitsu, is a leader in transdermal patch drug delivery, with deep expertise in complex patch systems. Directly comparable to Aveva's transdermal delivery capabilities, particularly in formulation and commercial-scale manufacturing.
- ARx, LLC: ARx is a private CDMO specializing in oral dissolvable films and transdermal patches, with manufacturing capabilities closely mirroring Aveva's core product lines. Strongly comparable as a mid-sized specialized drug delivery CMO serving pharma partners.
- Tapemark: Tapemark is a contract manufacturer specializing in transdermal patches, topical drug delivery systems, and oral dissolvable films. Comparable to Aveva as a specialized mid-sized US-based drug delivery CMO.
- AdhexPharma: AdhexPharma is a European-based pharmaceutical company specializing in transdermal drug delivery patches and oral films. Comparable to Aveva in technology, customer base (pharma partners), and dosage form specialization.
Broad incumbents
- LTS Lohmann Therapie-Systeme AG: LTS is one of the world's largest contract developers and manufacturers of transdermal patches and oral thin films, serving global pharmaceutical clients. As a broad incumbent, it is the largest scale competitor to Aveva in transdermal drug delivery manufacturing.
- Corium (Teva/GRT US Holding): Corium is a transdermal drug delivery specialist known for the Corplex technology platform, now operating under Teva/GRT US Holding. Comparable to Aveva in transdermal capabilities, with broader commercial product portfolio as an incumbent.
- Pfizer CentreOne: Pfizer CentreOne is the CMO/CDMO arm of Pfizer offering contract manufacturing services across multiple dosage forms. Comparable as a broad incumbent pharmaceutical CMO that competes for the same pharma partner manufacturing contracts as Aveva, though with much broader format coverage.
- Kindeva Drug Delivery: Kindeva Drug Delivery (formerly 3M Drug Delivery Systems) is a global CDMO specializing in inhalation, transdermal, and microneedle drug delivery. Comparable as a broad incumbent drug delivery CMO with capabilities overlapping Aveva's transdermal focus.
Others
- Carestream Health (Contract Manufacturing): While Carestream is best known for medical imaging, its contract manufacturing services overlap with pharmaceutical manufacturing partners. Less directly comparable, but functions in adjacent contract manufacturing space serving regulated healthcare industries.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks1 record
Key highlights5 records
Customer concentration
Aveva Drug Delivery Systems social profiles
Digital presenceAveva Drug Delivery Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aveva Drug Delivery Systems leadership team
Management profileNumber of profiles
Aveva Drug Delivery Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aveva Drug Delivery Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aveva Drug Delivery Systems
What does Aveva Drug Delivery Systems do?
Aveva Drug Delivery Systems is a contract manufacturing organization (CMO) that produces transdermal delivery systems (skin patches) and oral dissolvable thin films for pharmaceutical partners. The company specializes in complex drug delivery dosage forms used for personalized medicine, providing formulation and production capabilities to pharmaceutical companies that require advanced, US-based manufacturing.
Is Aveva Drug Delivery Systems a public or private company?
Aveva Drug Delivery Systems is a private company. It is classified as corporate owned and is currently operating.
When was Aveva Drug Delivery Systems founded?
Aveva Drug Delivery Systems was founded in 2023. It employs 251 to 500 people.
Where is Aveva Drug Delivery Systems based?
Aveva Drug Delivery Systems is headquartered in Miramar Beach, United States, in the North America region.
Who are Aveva Drug Delivery Systems's main competitors?
Direct peers on record are IntelGenx Technologies Corp, Noven Pharmaceuticals (Hisamitsu), ARx, LLC, Tapemark and AdhexPharma. Broad incumbents are LTS Lohmann Therapie-Systeme AG, Corium (Teva/GRT US Holding), Pfizer CentreOne and Kindeva Drug Delivery. Carestream Health (Contract Manufacturing) is listed as an others.
Does Aveva Drug Delivery Systems have an API?
No public API is recorded for Aveva Drug Delivery Systems.
What industry is Aveva Drug Delivery Systems in?
Aveva Drug Delivery Systems's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.